Antisense & RNAi Technology Market Research Reports & Industry Analysis
Antisense & RNAi Technology Industry Research & Market Reports
-
Global Antisense and RNAi Therapeutics Market 2019-2023
... and even rare diseases. Technavio’s analysts forecast the Global Antisense and RNAi Therapeutics Market to grow at a CAGR of 8.67% during the period 2019-2023. Covered in this report The report covers the present scenario ... Read More
-
Duchenne Muscular Dystrophy: KOL Insight [2018]
... known cure and few treatment options. Since 2014, two antisense oligonucleotide therapies [Exondys 51 (Sarepta Therapeutics) and Translarna (PTC Therapeutics)] have been approved but how are they faring on the market? Find out how key ... Read More
-
Antisense & RNAi Therapeutics Market Analysis Report By Technology (siRNA, miRNA), By Application (Oncology, Cardiovascular, Neurodegenerative Disorder), By Route of Administration, And Segment Forecasts, 2018 - 2025
... size is expected to reach USD 1.81 billion by 2025, according to a new report by Grand View Research, Inc., recording an 8.6% CAGR during the forecast period. Rising instances of external funding to conduct ... Read More
-
Oligonucleotide Synthesis Market by Product (Primer, Probe, Linker, Adaptor, Custom, Reagent, Equipment), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Academic, Pharmaceutical, Biotechnology) - Global Forecast to 2022
... to grow at a CAGR of 10.9%.” The global oligonucleotide synthesis market is expected to reach USD 2.46 billion by 2022 from USD 1.47 billion in 2017 at a CAGR of 10.9%. This market is ... Read More
-
The 2019-2024 World Outlook for Ribonucleic Acid (RNA) Analysis and Transcriptomics
... are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These ... Read More
-
The 2019-2024 World Outlook for RNAi Therapies
... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More
-
The 2019-2024 World Outlook for Antisense and RNA Interference (RNAi) Therapeutics
... are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These ... Read More
-
The 2019-2024 World Outlook for RNA Interference (RNAi) Technologies
... latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the ... Read More
-
Global RNAi Technology Market
... CAGR of 20.19% RNA interference (RNAi) is a natural process of treating forms of cancer and other diseases by post-transcriptional silencing of genes by small fragments of the nucleic acid. However, the path of RNAi ... Read More
-
Biologics Market Analysis By Source (Microbial, Mammalian), By Products (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi, & Molecular Therapy), By Disease Category, By Manufacturing, And Segment Forecasts, 2014 - 2025
... is anticipated to reach USD 399.5 billion by 2025, according to a new report by Grand View Research, Inc. Introduction of targeted therapies coupled with rising adoption of patient centric personalized medicine anticipated to fuel ... Read More
-
The 2018-2023 World Outlook for Ribonucleic Acid (RNA) Analysis and Transcriptomics
... are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These ... Read More
-
The 2018-2023 World Outlook for RNA Interference (RNAi) Technologies
... latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the ... Read More
-
The 2018-2023 World Outlook for RNAi Therapies
... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More
-
Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, Custom, Predesigned, Reagent Equipment), Application (Research, PCR, Gene, DNA, NGS, Diagnostic, RNAI), End user (Academic, Pharmaceutical, Biotechnology) - Forecasts to 2021
... market is poised to reach USD 2.20 billion by 2021 from USD 1.33 billion in 2016, growing at a CAGR of 10.6% from 2016 to 2021. Major factors contributing to the growth of the global ... Read More
-
Drug Discovery Technologies - Global Market Outlook (2016-2022)
... growing at a CAGR of XX% from 2015 to 2022. Rise in new diseases and growing demand for therapeutics in various diseases are the factors driving the market growth. Stringent regulations and high initial cost ... Read More
-
Genome Editing Global Market - Forecast to 2022
... a continuous evolution of gene modification technique starting from restriction endonucleases, transgenic breeding, RNAi technologies to the current engineered endonucleases. Over the last several decades, technologies for identification, isolation, sequencing, replication and integration of desired ... Read More
-
RNA (miRNA, RNAi & siRNA) Therapies in Cancer: Analytical Tool
... empower biotech/pharma professionals from a business development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early ... Read More
-
RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer
... treatment of more than 41 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 90 drug targets that are included in this drug-pathway analyzing tool. ... Read More
-
RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update
... or protein-based therapies. There are today 103 companies plus partners developing 131 RNA (miRNA, RNAi & siRNA) drugs in 198 developmental projects in cancer. In addition, there are 2 suspended drugs and the accumulated number ... Read More
-
MicroRNA Tools and Services Market
... (North America, Europe, rest of world); world market and projections for miRNA tools and services, 2013-2016 and 2020 (miRNA analysis tools, miRNA services, total revenues); world market and projections for miRNA analysis tools and services ... Read More
-
Conference Documentation: RNA Therapeutics
... in oncology, cardiovascular injury, and ophthalmology, and open the floor for discussion to review existing and emerging concepts in delivery systems, oligonucleotides, aptamer-conjugates as well as messenger RNA therapeutics. The biggest challenge in enabling RNAi ... Read More
-
Global CRISPR Market, By Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation And Forecast 2015 – 2021
... is a gene editing tool. CRIPSR commercialization began in 2012 with emergence of number of startups and venture capitalists and showing their interest in infusing money into this technology. Academic and research firms are the ... Read More
-
RNAi Technologies and Global Markets
... 8.4%. This report provides: An overview of the global market for RNAi technologies which are used in the areas of drug delivery, therapeutics, and diagnostics Analyses of global market trends, with data from 2014, estimates ... Read More
-
RNAi Therapeutics Market, 2015 - 2030
... involving short strands of nucleic acids. It is a regulatory process that cells utilise to silence and/or inhibit gene expression through the destruction of specific mRNA molecules. One of the major advantages of RNAi is ... Read More
-
Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, Custom Oligos, Reagent, Equipment), Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global Forecast to 2020
... synthesis market is poised to reach USD 1,918.6 million by 2020 from USD 1,078.1 million in 2015, growing at a CAGR of 10.1% from 2015 to 2020. This market is categorized on the basis of ... Read More
